Abstract
Peptide nucleic acids (PNA) are artificial structural mimics of nucleic acids capable of sequence specific hybridization to both RNA and DNA. Thus they have obvious potential as gene targeting agents for drug discovery approaches. An overview with emphasis on recent progress on RNA “interference” (antisense), targeting of duplex DNA and gene targeted repair and transcription interference using PNA, as well as on PNA delivery and potential PNA anti-infectives is given.
Keywords: Gene targeting, antisense, PNA, delivery, transcription
Current Pharmaceutical Design
Title: Gene Targeting and Expression Modulation by Peptide Nucleic Acids (PNA)
Volume: 16 Issue: 28
Author(s): Peter E. Nielsen
Affiliation:
Keywords: Gene targeting, antisense, PNA, delivery, transcription
Abstract: Peptide nucleic acids (PNA) are artificial structural mimics of nucleic acids capable of sequence specific hybridization to both RNA and DNA. Thus they have obvious potential as gene targeting agents for drug discovery approaches. An overview with emphasis on recent progress on RNA “interference” (antisense), targeting of duplex DNA and gene targeted repair and transcription interference using PNA, as well as on PNA delivery and potential PNA anti-infectives is given.
Export Options
About this article
Cite this article as:
E. Nielsen Peter, Gene Targeting and Expression Modulation by Peptide Nucleic Acids (PNA), Current Pharmaceutical Design 2010; 16 (28) . https://dx.doi.org/10.2174/138161210793292546
DOI https://dx.doi.org/10.2174/138161210793292546 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Agaricus blazei Water Extracts as Alternative Medicines
Current Pharmaceutical Analysis Beyond Oncolytic Virotherapy: Replication-Competent Retrovirus Vectors for Selective and Stable Transduction of Tumors
Current Gene Therapy Life and Death of Nerve Cells: Therapeutic Cytokine Signaling Pathways
Current Signal Transduction Therapy Subunit Protein Vaccines: Theoretical and Practical Considerations for HIV-1
Current Molecular Medicine Acanthamoeba-Bacteria: A Model to Study Host Interaction with Human Pathogens
Current Drug Targets The Role of Immune System in Schizophrenia
Current Immunology Reviews (Discontinued) Amygdalar Atrophy in Early Alzheimer’s Disease
Current Alzheimer Research Structural Disorder within the Measles Virus Nucleoprotein and Phosphoprotein
Protein & Peptide Letters The Role of Microglial Cell Subsets in Alzheimers Disease
Current Alzheimer Research Biosafety Considerations Using Gamma-Retroviral Vectors in Gene Therapy
Current Gene Therapy Immunotherapy for Targeting Tau Pathology in Alzheimer’s Disease and Tauopathies
Current Alzheimer Research Therapeutic Perspectives of Drugs Targeting Toll-Like Receptors Based on Immune Physiopathology Theory of Alzheimers Disease
CNS & Neurological Disorders - Drug Targets A DNA Barcoding Based Study to Identify Main Mosquito Species in Taiwan and its Difference from Those in Mainland China
Combinatorial Chemistry & High Throughput Screening The Role of VE-cadherin in Blood-brain Barrier Integrity Under Central Nervous System Pathological Conditions
Current Neuropharmacology Autoantibodies in Autoimmune Diseases
Current Pharmaceutical Design Calcium Antagonists: A Ready Prescription for Treating Infectious Diseases?
Current Topics in Medicinal Chemistry Interleukin 10 in Antiviral Responses
Current Immunology Reviews (Discontinued) Animal Models for Obsessive-Compulsive Disorder
Current Neuropharmacology Tofacitinib-induced Ramsay- Hunt Syndrome in a Patient with Rheumatoid Arthritis
Current Drug Safety Progressive Supranuclear Palsy: What Do We Know About it?
Current Medicinal Chemistry